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β-cryptoxanthin, a type of carotenoid, is contained in Citrus unshiu that is a representative citrus in 
Japan. Nutritional epidemiological surveys of humans in Japan and abroad and basic research using 
experimental animals have revealed that β-cryptoxanthin has a suppressing effect on the initiation and 
progression of various lifestyle-related diseases such as osteoporosis, obesity, and fatty liver. 
Osteoarthritis (OA) is a disease that causes joint inflammation, swelling, and pain due to mechanical 
load, and it is the main cause of the locomotive syndrome. Neuropathic pain is caused by neurological 
disorders and dysfunction. For either diseases, effective preventive methods or treatments have not been 
established. In this study, the preventive effect of β-cryptoxanthin on the initiation and progression of 
OA and neuropathic pain was examined using each model animal. 
β-cryptoxanthin was orally administered to mice in which OA surgery was performed. The degree of 
OA progression was evaluated using the degree of cartilage destruction as an index by histological 
analysis of the knee joint. The result showed that orally ingested β-cryptoxanthin suppressed cartilage 
destruction, which led to markedly suppressed OA progression. Furthermore, we found that β-
cryptoxanthin has a marked inhibitory effect on expression of inflammatory cytokines in an in vitro 
experimental system using chondrocytes. Furthermore, we created a neuropathic pain mouse model. β-
cryptoxanthin was administered orally to the mice of this model and the initiation and progression were 
evaluated with the threshold for filament stimulation as an index. We found orally ingested β-
cryptoxanthin inhibited a decrease in the threshold to the stimulus, and the onset of neuropathic pain 
was markedly suppressed. 
These results indicated that oral intake of β-cryptoxanthin may be beneficial for new preventive 
approaches to OA and neuropathic pain, which is a major cause of divergence between healthy 































のOAの進展度を評価した。さらに、Osteoarthritis Research Society International（OARSI）提
唱の組織学的定量化システムにより定量化した。 











を交換した。28日間連続投与を行い、手術後 1、3、5、7、14日目に Von frey hair と呼ばれ
るフィラメントを用いて刺激を加え、急性痛を評価した。 
④ 炎症性疼痛モデルの作製  























































以上の研究成績は、β-CRY の経口摂取が、健康寿命短縮の主要因である OA および神経因性疼痛
に対する新しい予防的アプローチに有益である可能性が示された点で評価されるため、審査委員会
は本論文が博士（創薬科学）に値すると判断した。 
